Hyperleptinemia: Implications on the inflammatory state and vascular protection in obese adolescents submitted to an interdisciplinary therapy

Inflammation

Volumn 37, Issue 1, 2014, Pages 35-43

  Sanches, Priscila L ^a   De Mello, Marco T ^a   Elias, Natália ^a   Fonseca, Francisco A H ^a   Campos, Raquel M S ^a   Carnier, June ^a   De Piano, Aline ^a   Masquio, Deborah C L ^a   Silva, Patrícia L ^a   Oyama, Lila M ^a   Corgosinho, Flavia C ^a   Nascimento, Cláudia M O ^a   Tock, Lian ^a   D'Elia, Carolina Ackel ^a   Tufik, Sergio ^a   Dâmaso, Ana R ^a,b,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Unifesp   (Brazil)

^c Universidade Federal de São Paulo ^*  (Brazil)

Author keywords

adiponectin; hyperleptinemia; interdisciplinary therapy; obesity; vascular protection

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; AEROBIC EXERCISE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; BODY COMPOSITION; BODY FAT; BODY MASS; CARDIOVASCULAR FUNCTION; CHILDHOOD OBESITY; CLINICAL ARTICLE; FEMALE; GLUCOSE METABOLISM; HUMAN; HYPERLEPTINEMIA; INFLAMMATION; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; MALE; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PHYSIOTHERAPY; PROTECTION; PSYCHOTHERAPY; RESISTANCE TRAINING; SUBCUTANEOUS FAT; WEIGHT REDUCTION;

ADIPONECTIN; ADIPOSE TISSUE; ADIPOSITY; ADOLESCENT; BLOOD GLUCOSE; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LEPTIN; LIFE STYLE; MALE; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; WEIGHT REDUCTION PROGRAMS;

EID: 84900357841     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9709-9     Document Type: Article

References (39)

1. Zhang, H., J. Cui, and C. Zhang. 2010. Emerging role of adipokines as mediators in atherosclerosis. World Journal of Cardiology 2(11): 370-376.
2. Bełtowski, J. 2012. Leptin and the regulation of endothelial function in physiological and pathological conditions. Clinical and Experimental Pharmacology and Physiology 39(2): 168-178.
3. Mantzoros, C.S., F. Magkos, M. Brinkoetter, E. Sienkiewicz, T.A. Dardeno, S.Y. Kim, O.P. Hamnvik, and A. Koniaris. 2011. Leptin in human physiology and pathophysiology. American Journal of Physiology, Endocrinology and Metabolism 301(4): E567-E584.
4. Martin, S.S., A. Qasim, and M.P. Reilly. 2008. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. Journal of the American College of Cardiology 52(15): 1201-1210.
5. Dâmaso, A.R., A. de Piano, P.L. Sanches, F. Corgosinho, L. Tock, L.M. Oyama, L. Tock, C.M. do Nascimento, S. Tufik, and M.T. de Mello. 2011. Hyperleptinemia in obese adolescents deregulates neuropeptides during weight loss. Peptides 32(7): 1384-1391.
6. González, M., Bibiloni M. DelMar, A. Pons, I. Llompart, and J.A. Tur. 2012. Inflammatory markers and metabolic syndrome among adolescents. European Journal of Clinical Nutrition 66(10): 1141-1145.
7. Matsuzawa, Y. 2005. Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atherosclerosis Supplements 6(2): 7-14.
8. Beauloye, V., F. Zech, H.T. Tran, P. Clapuyt, M. Maes, and S.M. Brichard. 2007. Determinants of early atherosclerosis in obese children and adolescents. Journal of Clinical Endocrinology and Metabolism 92: 3025-3032. (Pubitemid 47236366)
9. Corgosinho, F.C., A. de Piano, P.L. Sanches, R.M. Campos, P.L. Silva, J. Carnier, L.M. Oyama, L. Tock, S. Tufik,M.T. deMello, and A.R. Dâmaso. 2012. The role of PAI-1 and adiponectin on the inflammatory state and energy balance in obese adolescents with metabolic syndrome. Inflammation 35(3): 944-951.
10. de Lima, Sanches P., M.T. de Mello, N. Elias, F.A. Fonseca, A. de Piano, J. Carnier, L.M. Oyama, L. Tock, S. Tufik, and A.R. Dâmaso. 2011. Improvement in HOMA-IR is an independent predictor of reduced carotid intima-media thickness in obese adolescents participating in an interdisciplinary weight-loss program. Hypertension Research 34(2): 232-238.
11. Korda, M., R. Kubant, S. Patton, and T. Malinski. 2008. Leptin-induced endothelial dysfunction in obesity. American Journal of Physiology-Heart and Circulatory Physiology 295(4): 1514-1521.
12. Brennan, A.M., T.Y. Li, I. Kelesidis, A. Gavrila, F.B. Hu, and C.S. Mantzoros. 2007. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study. Diabetologia 50: 1178-1185. (Pubitemid 46701547)
13. Matarese, G., C. Mantzoros, and A. La Cava. 2007. Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis. Current Pharmaceutical Design 13: 3676-3680.
14. Tanner, J.M., and R.H. Whitehouse. 1976. Clinical longitudinal standards for height, weight, weight velocity and stages of puberty. Archives of Disease in Childhood 51: 170-179.
15. Centers for Disease Control and Prevention. Hyattsville: National Center for Health Statistics. (Updates on 11 January 2007; accessed on 15 August 2011). Prevalence ofoverweight among children and adolescents: United States 1999-2002. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/overwght99.htm.
16. Gutin, B., L. Ramsey, P. Barbeau, W. Cannady, M. Ferguson, M. Litaker, and S. Owens. 1999. Plasma leptin concentrations in obese children: changes during 4-mo periods with and without physical training. American Journal of Clinical Nutrition 69: 388-394. (Pubitemid 29104557)
17. de Piano, A., W.L. Prado, D.A. Caranti, K.O. Siqueira, S.G. Stella, M. Lofrano, L. Tock, D.M. Cristofalo, H. Lederman, S. Tufik, M.T. de Mello, and A.R. Dâmaso. 2007. Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease. Journal of Pediatric Gastroenterology and Nutrition 44: 446-452. (Pubitemid 46573227)
18. Guardamagna, O., F. Abello, P. Saracco, V. Baracco, E. Rolfo, and M. Pirro. 2009. Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia. Atherosclerosis 207: 471-475.
19. Rabago Rodriguez, R., R.A. Gómez-Díaz, J. Tanus Haj, F.J. Avelar Garnica, E. Ramirez Soriano, E. Nishimura Meguro, C.A. Aguilar-Salinas, and N.H. Wacher. 2007. Carotid intima-media thickness in pediatric type 1 diabetic patients. Diabetes Care 30: 2599-2602. (Pubitemid 47547803)
20. Friedewald, W., R. Levy, and D. Friderickson. 1972. Estimation of the concentration of low density protein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18: 449-515.
21. Quijada, Z., M. Paoli, Y. Zerpa, N. Camacho, R. Cichetti, V. Villarroel, G. Arata-Bellabarba, and R. Lanes. 2008. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. Pediatric Diabetes 9: 464-471.
22. Matsuhisa, M., Y. Yamasaki, M. Emoto, M. Shimabukuro, T. Funahashi, and Y. Matsuzawa. 2007. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects. Diabetes Research and Clinical Practice 77: 151-154. (Pubitemid 46590462)
23. Chobanian, A.V., G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr., D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright Jr., E.J. Roccella, and National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. 2003. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Journal of the American Medical Association 289(19): 2560-2572. (Pubitemid 37430158)
24. Giuliano, I.C.B., B. Caramelli, L. Pellanda, B. Duncan, S.Mattos, and F.A.H. Fonseca. 2006. I Guideline for preventing atherosclerosis in childhood and adolescence. International Atherosclerosis 1: 1-30.
25. NRC. 2001. Dietary reference intake: applications in dietary assessment. Washington, DC: National Academic Press.
26. Donnelly, J.E., S.N. Blair, J.M. Jakicic, M.M. Manore, J.W. Rankin, and B.K. Smith. 2009. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Medicine & Science in Sports & Exercise 41: 459-471.
27. Kelishadi, R., M. Hashemi, N. Mohammadifard, S. Asgary, and N. Khavarian. 2008. Association of changes in oxidative and proinflammatory states with changes in vascular function after a lifestyle modification trial among obese children. Clinical Chemistry 54(1): 147-153. (Pubitemid 351182608)
28. Monzavi, R., D. Dreimane, M.E. Geffner, S. Braun, B. Conrad, M. Klier, and F.R. Kaufman. 2006. Improvement in risk factors for metabolic syndrome and insulin resistance in overweight youth who are treated with lifestyle intervention. Pediatrics 117: e1111-e1118. (Pubitemid 46071206)
29. Matarese, G., S. Moschos, and C.H. Mantzoros. 2005. Leptin in immunology. Journal of Immunology 173: 3137-3142. (Pubitemid 40354011)
30. Zhao, Y., R. Sun, L. You, C. Gao, and Z. Tian. 2003. Expression of leptin receptor and response to leptin stimulation of human natural killer cell lines. Biochemical and Biophysical Research Communications 300(2): 247-252. (Pubitemid 38375801)
31. Li, F.Y., K.K. Cheng, K.S. Lam, P.M. Vanhoutte, and A. Xu. 2011. Cross-talk between adipose tissue and vasculature: role of adiponectin. Acta Physiologica (Oxford, England) 203(1): 167-180.
32. Ohashi, K., N. Ouchi, and Y. Matsuzawa. 2012. Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie 94(10): 2137-2142.
33. Ouchi, N., and K. Walsh. 2007. Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta 380(1-2): 24-30. (Pubitemid 46498041)
34. Norata, G.D., S. Raselli, L. Grigore, K. Garlaschelli, E. Dozio, P. Magni, and A.L. Catapano. 2007. Leptin: adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 38: 2844-2846. (Pubitemid 47494027)
35. Makni, E., W. Moalla, G. Lac, C. Aouichaoui, D. Cannon, M. Elloumi, and Z. Tabka. 2012. The Homeostasis Model Assessment-adiponectin (HOMA-AD) is the most sensitive predictor of insulin resistance in obese children. Annales d' endocrinologie 73(1): 26-33..
36. Dullaart, R.P., R. de Vries, A. Van Tol, andW.J. Sluiter. 2007. Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender. European Journal of Endocrinology 156: 387-394. (Pubitemid 46554507)
37. Singh, P., T.E. Peterson, K.R. Barber, F.S. Kuniyoshi, A. Jensen, M. Hoffmann, A.S. Shamsuzzaman, and V.K. Somers. 2010. Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells. Biochemical and Biophysical Research Communications 392(1): 47-52.
38. Lijnen, H.R. 2005. Pleiotropic functions of plasminogen activator inhibitor-1. Journal of Thrombosis and Haemostasis 3(1): 35-45. (Pubitemid 41647113)
39. Scotece, M., J. Conde, R. Gómez, V. López, J. Pino, A. González, F. Lago, J.J. Gómez-Reino, and O. Gualillo. 2012. Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases. Mediators of Inflammation 125458.